These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 18687757)

  • 1. National health care costs of peripheral arterial disease in the Medicare population.
    Hirsch AT; Hartman L; Town RJ; Virnig BA
    Vasc Med; 2008 Aug; 13(3):209-15. PubMed ID: 18687757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
    Jaff MR; Cahill KE; Yu AP; Birnbaum HG; Engelhart LM
    Ann Vasc Surg; 2010 Jul; 24(5):577-87. PubMed ID: 20579582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey.
    Hirsch AT; Murphy TP; Lovell MB; Twillman G; Treat-Jacobson D; Harwood EM; Mohler ER; Creager MA; Hobson RW; Robertson RM; Howard WJ; Schroeder P; Criqui MH;
    Circulation; 2007 Oct; 116(18):2086-94. PubMed ID: 17875966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment cost of acute exacerbations of chronic bronchitis.
    Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
    Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient costs of osteoporosis in a national health insurance population.
    Krappweis J; Rentsch A; Schwarz UI; Krobot KJ; Kirch W
    Clin Ther; 1999 Nov; 21(11):2001-14. PubMed ID: 10890269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of fruit and vegetable consumption in middle-aged men to medicare expenditures in older age: the Chicago Western Electric Study.
    Daviglus ML; Liu K; Pirzada A; Yan LL; Garside DB; Wang R; Van Horn L; Manning WG; Manheim LM; Dyer AR; Greenland P; Stamler J
    J Am Diet Assoc; 2005 Nov; 105(11):1735-44. PubMed ID: 16256757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic implications of treating atherothrombotic disease in Australia, from the government perspective.
    Ademi Z; Liew D; Hollingsworth B; Wolfe R; Steg GP; Bhatt DL; Reid CM;
    Clin Ther; 2010 Jan; 32(1):119-32; discussion 106-7. PubMed ID: 20171418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.
    Daviglus ML; Liu K; Greenland P; Dyer AR; Garside DB; Manheim L; Lowe LP; Rodin M; Lubitz J; Stamler J
    N Engl J Med; 1998 Oct; 339(16):1122-9. PubMed ID: 9770560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study.
    Schauffler HH; D'Agostino RB; Kannel WB
    Am J Prev Med; 1993; 9(3):146-54. PubMed ID: 8347365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
    Coleman AL; Yu F
    Ophthalmology; 2008 Jan; 115(1):18-25. PubMed ID: 17572499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in lumbosacral injections in the Medicare population: 1994 to 2001.
    Friedly J; Chan L; Deyo R
    Spine (Phila Pa 1976); 2007 Jul; 32(16):1754-60. PubMed ID: 17632396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.